No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Radiopharm Approved to Start Lu-RAD202 Safety Trials, Door Open for In-human Studies
ASX Small-Cap Stocks to Watch
Radiopharm Theranostics Completes Preclinical Package for Radiotherapeutic Product; Shares Slump 17%
Radiopharm Theranostics Secures Ethics Approval to Expand Phase 1 Cancer Trial; Shares Up 4%
Radiopharm Extends Radioimmunotherapy Trial to 5 More Cancer Types
Radiopharm Theranostics Teams Up With AtomVie Global Radiopharma for Antibody Development; Shares Up 4%